Navigation Links
Therapure Biopharma Inc. Signs Biomanufacturing Contract with ProChon Biotech Ltd.
Date:6/21/2010

Therapure Biopharma Inc. today announced an agreement under which Therapure will provide manufacturing services for ProChon Biotech, a specialty pharmaceutical company based in Israel with an executive management team based in Woburn, MA. Under the terms of the agreement, Therapure will provide services to support clinical manufacturing for one of ProChon’s products, which may be used for reconstructive surgery. The companies are also negotiating contracts for on-going manufacturing services, subject to the product achieving FDA approval. Financial terms were not disclosed.

Toronto, ON (PRWEB) June 21, 2010 -- Therapure Biopharma Inc. today announced an agreement under which Therapure will provide manufacturing services for ProChon Biotech, a specialty pharmaceutical company based in Israel with an executive management team based in Woburn, MA. Under the terms of the agreement, Therapure will provide services to support clinical manufacturing for one of ProChon’s products, which may be used for articular cartilage regeneration. The companies are also negotiating contracts for on-going manufacturing services, subject to the product achieving FDA approval. Financial terms were not disclosed.

ProChon Biotech Limited (Prochon) is a privately owned biotechnology company focused on providing products for articular cartilage regeneration. Prochon’s expertise in modulating the fibroplast growth factor (FGF) enables it to create more effective solutions for tissue regeneration.

“We are pleased to have been chosen by Prochon as its partner to provide clinical manufacturing services” said Thomas Wellner, President and CEO of Therapure. “Therapure has performed these services for a number of clients and has demonstrated market leading expertise.” continued Mr. Wellner.

“We believe that Therapure has the most relevant expertise for successful implementation of our manufacturing requirements.” said Patrick O’Donell, CEO of Prochon Inc.

About Therapure Biopharma Inc.:
Therapure Biopharma Inc. is an integrated biopharmaceutical company that develops, manufactures, purifies and packages therapeutic proteins. As a contract development and manufacturing organization (CDMO) Therapure Biopharma applies scientific, manufacturing, and downstream purification expertise with an intimate understanding of advanced biology, complex proteins, and regulatory processes to develop effective and innovative solutions to advance products from discovery to market for its clients. Therapure’s Health Canada licensed 130,000 sq. ft. facility, includes manufacturing, research and quality control laboratories and a cGMP warehouse, and is built to U.S. FDA, EMEA, MHRA and Health Canada standards for the aseptic handling and purification of proteins.

For more information, please visit: www.therapurebio.com

Company Contacts:

Thomas Wellner, President and CEO
Therapure Biopharma Inc.
+1 905 286-6204

###

Read the full story at http://www.prweb.com/releases/biopharma/manufacturing/prweb4162674.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Microbix And Therapure Biopharma Form Partnership To Expand Water-Based Supplies To The Pharma Industry
2. YM BioSciences Inc. and Therapure Biopharma Inc. Announce Contract
3. Therapure Biopharma Inc. Announces Manufacturing Agreement with Biomedical Frontiers Incorporated -- Contract will Support Phase II Trials for Thalassemia Treatment
4. Therapure Biopharma Inc. announces collaboration with BioVectra Inc.
5. Therapure Biopharma Inc. announces collaboration with Induce Biologics Inc.
6. Therapure Biopharma Inc. opens for business with first client contracts
7. Chinese Biopharmaceutical Association Holds 15th Annual Conference in Rockville, MD, June 12 - 13
8. IntraLinks Announces Partnership With SAFE-BioPharma; Will Provide Digital Identity Capabilities With its Life Sciences Solutions
9. PDL BioPharma to Announce First Quarter 2010 Financial Results and Hold Conference Call on April 29, 2010
10. PDL BioPharma Announces Fourth Quarter and Full Year 2009 Financial Results and Provides First Quarter 2010 Revenue Guidance
11. ClearTrial Launches New Service to Bring Speed and Accuracy in Clinical Trial Planning Within Reach of Smaller Biopharma Companies
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Therapure Biopharma Inc. Signs Biomanufacturing Contract with ProChon Biotech Ltd.
(Date:4/27/2016)... ... ... Shimadzu Scientific Instruments (SSI) will be showcasing a broad ... Expo. Shimadzu’s high-performance instruments enable laboratories to test cannabis products for potency, moisture, ... booth 1021 to learn how Shimadzu’s instruments can help improve QA/QC testing, peak ...
(Date:4/27/2016)... Columbia , April 27, 2016 ... "NanoStruck") (CSE: NSK) (OTCPink: NSKQB) ( Frankfurt ... Anschluss an ihre Pressemitteilung vom 13. August 2015 ... hat, ihre Finanzen um zusätzliche 200.000.000 Einheiten auf ... Kanadische Dollar zu bringen. Davon wurden 157.900.000 Einheiten ...
(Date:4/27/2016)... ... April 27, 2016 , ... NDA ... joined the company as an Expert Consultant. Mr. Clark was formerly a ... managing the development of small molecule monographs based on analytical methods. NDA ...
(Date:4/27/2016)... ... ... Global Stem Cells Group CEO Benito Novas announced that Duncan ... affiliate Kimera Labs in Miami. , In 2004, Ross received his Ph.D. in Immunology ... disorders and the suppression of graft vs. host disease (GVHD) under UM Professor Robert ...
Breaking Biology Technology:
(Date:3/31/2016)... 2016   LegacyXChange, ... "Company") LegacyXChange is excited to release its ... to be launched online site for trading 100% guaranteed ... will also provide potential shareholders a sense of the ... an industry that is notorious for fraud. The video ...
(Date:3/22/2016)... , March 22, 2016 ... research report "Electronic Sensors Market for Consumer Industry by ... & Others), Application (Communication & IT, Entertainment, ... - Global Forecast to 2022", published by ... is expected to reach USD 26.76 Billion ...
(Date:3/17/2016)... 17, 2016 ABI Research, the leader ... global biometrics market will reach more than $30 ... from 2015. Consumer electronics, particularly smartphones, continue to ... anticipated to reach two billion shipments by 2021 ... Pavlakis , Research Analyst at ABI Research. "Surveillance ...
Breaking Biology News(10 mins):